Averkaz

Averkaz

montelukast

Manufacturer:

ACME

Distributor:

Euro Generics
Concise Prescribing Info
Contents
Montelukast Na
Indications/Uses
Management of chronic asthma, allergic rhinitis. Prophylaxis for exercise-induced asthma.
Dosage/Direction for Use
Doses to be given once daily at bed time. Chewable tab Childn 6-14 yr 5 mg. FC tab Adult ≥15 yr 10 mg.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Hepatic impairment or cirrhosis.
Special Precautions
Not indicated for use in acute asthma attacks. Not to be used as monotherapy for the treatment & management of exercise-induced bronchospasm. Pregnancy & lactation. Childn <2 yr.
Adverse Reactions
GI disturbances, dry mouth, thirst; hypersensitivity reactions including anaphylaxis, angioedema & skin reactions; asthenia, dizziness, irritability, restlessness, headache, sleep disorders (insomnia, drowsiness, nightmares); upper resp tract infection, fever, arthralgia, myalgia.
Drug Interactions
Potent CYP450 enzyme inducers eg, phenobarb or rifampin.
ATC Classification
R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Presentation/Packing
Form
Averkaz FC tab 10 mg
Packing/Price
15's
Form
Averkaz chewable tab 5 mg
Packing/Price
30's
Form
Averkaz chewable tab 4 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in